Company Overview of Maxygen, Inc.
Maxygen, Inc., a biopharmaceutical company, focuses on the discovery and development of protein pharmaceuticals for the treatment of disease and serious medical conditions in the United States. It focuses on developing MAXY-G34 product candidate, a granulocyte colony stimulating factor, for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome. The company was founded in 1996 and is headquartered in San Mateo, California.
411 Borel Avenue
San Mateo, CA 94402
Founded in 1996
Key Executives for Maxygen, Inc.
Maxygen, Inc. Key Developments
Similar Private Companies By Industry
|Amydis Diagnostics, Inc.||United States|
|Millennium Predictive Medicine, Inc.||United States|
|rEVO Biologics, Inc.||United States|
|Lazarus Therapeutics LLC||United States|
|Target Discovery, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Maxygen, Inc., please visit www.maxygen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.